Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
MesenCure by Bonus BioGroup for Acute Respiratory Distress Syndrome: Likelihood of Approval
MesenCure is under clinical development by Bonus BioGroup and currently in Phase II for Acute Respiratory Distress Syndrome. According to...